CU-CPTdos2 was used since the site TLR2-antagonist

CU-CPTdos2 was used since the site TLR2-antagonist Biological validation To explore the activity of the synthesized and selected compounds 1 to 6 and 9 to 11 on the TLR2 activity, reporter cells overexpressing hTLR2 were used. 7, 10a, 11 Except for 1, all selected compounds decreased TLR2-mediated NF-?B activation in